Home/Filings/4/0001127602-21-015391
4//SEC Filing

BELINGARD JEAN-LUC 4

Accession 0001127602-21-015391

CIK 0000920148other

Filed

May 4, 8:00 PM ET

Accepted

May 5, 10:48 AM ET

Size

8.7 KB

Accession

0001127602-21-015391

Insider Transaction Report

Form 4
Period: 2021-05-03
Transactions
  • Sale

    Common Stock

    2021-05-03$269.16/sh2,600$699,80315,569 total
  • Exercise/Conversion

    Common Stock

    2021-05-03$98.49/sh+2,600$256,07418,169 total
  • Exercise/Conversion

    Non-qualified Stock Options

    2021-05-032,6000 total
    Exercise: $98.49From: 2012-05-11Exp: 2021-05-11Common Stock (2,600 underlying)
Footnotes (3)
  • [F1]The price of $269.1551 per share represents a weighted average of sales prices ranging from $269.06 to $269.291 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  • [F2]Director stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
  • [F3]The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.

Issuer

LABORATORY CORP OF AMERICA HOLDINGS

CIK 0000920148

Entity typeother

Related Parties

1
  • filerCIK 0001200845

Filing Metadata

Form type
4
Filed
May 4, 8:00 PM ET
Accepted
May 5, 10:48 AM ET
Size
8.7 KB